Middle East and Africa Pharmaceutical Glass Packaging Market, By Material (Type I, Type II, and Type III), Product (Bottles, Ampoules, Cartridges and Syringes, Vials, and Others), Drug Type (Generic, Branded, and Biologic) Application (Oral, Injectable, Nasal, and Others), End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development, and Manufacturing Companies, Compound Pharmacy, and Others) – Industry Trends and Forecast to 2031.
Middle East and Africa Pharmaceutical Glass Packaging Market Analysis and Size
Medicinal products encompass a wide range of pharmaceutical formulations, including tablets, capsules, liquids, and injectables, all of which require reliable packaging to maintain their efficacy and safety. Pharmaceutical glass packaging companies serves a preferred choice for storing and dispensing these products due to its inert nature, which prevents chemical interactions and maintains product integrity. Glass containers from pharmaceutical glass packaging market offer excellent barrier properties, protecting medicines from moisture, light, and oxygen, thereby extending their shelf life.
The Middle East and Africa pharmaceutical glass packaging market size was valued at USD 3,23,002.47 thousand in 2023 and is projected to reach USD 5,59,141.35 thousand by 2031, with a CAGR of 7.1% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Material (Type I, Type II, and Type III), Product (Bottles, Ampoules, Cartridges and Syringes, Vials, and Others), Drug Type (Generic, Branded, and Biologic) Application (Oral, Injectable, Nasal, and Others), End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development, and Manufacturing Companies, Compound Pharmacy, and Others)
|
|
Countries Covered
|
U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and Africa and the rest of Middle East and Africa
|
|
Market Players Covered
|
RAK Ghani Glass LLC (U.A.E.), APG (Asia Pulp & Paper Group) (Indonesia), Middle East Glass – MEG (Egypt), Bormioli Pharma S.p.a (Italy), FRIGOGLASS AG (Switzerland), and Medicinal Glass CO., Ltd. (China)
|
|
Market Opportunities
|
|
Market Definition
Pharmaceutical glass packaging refers to containers made from glass specifically designed for storing and transporting pharmaceutical products such as medicines, vaccines, and injectables. These containers, including vials, ampoules, bottles, and syringes, ensure the integrity, safety, and efficacy of the enclosed pharmaceuticals, protecting them from contamination, light, and environmental factors.
Pharmaceutical Glass Packaging Market Dynamics
Drivers
- Rising Stringent Regulations
Regulatory bodies worldwide impose strict guidelines on packaging materials to ensure the protection of medicinal products from contamination, degradation, and tampering. Glass packaging is favored for pharmaceuticals due to its inert nature, which minimizes the risk of chemical interactions and maintains product stability. Regulations also govern aspects such as sterility and barrier properties, further emphasizing the suitability of glass containers. Compliance with these regulations necessitates pharmaceutical companies to invest in reliable packaging solutions, driving the demand for pharmaceutical glass packaging and propelling the market growth.
- Growing Demand for Biopharmaceuticals
Biopharmaceuticals, including proteins, antibodies, and vaccines, often require specialized packaging to maintain stability and efficacy. Glass containers are preferred for biopharmaceuticals due to their inert and non-reactive properties, which minimize the risk of chemical interactions and degradation of sensitive biologics. In addition, glass provides excellent barrier properties, protecting biopharmaceuticals from moisture, oxygen, and light, thus extending their shelf life. As the biopharmaceutical sector continues to grow, the demand for pharmaceutical glass packaging is expected to rise, creating opportunities for glass packaging manufacturers to cater to this specialized market segment.
Opportunities
- Advancements in Drug Delivery Technologies
Glass containers offer several advantages for these innovative delivery systems, including compatibility with a wide range of drug formulations, excellent barrier properties to maintain drug stability, and inertness to prevent chemical interactions. The rise in self-administered injectable therapies and biopharmaceuticals further underscores the need for reliable and safe packaging solutions provided by pharmaceutical glass packaging. Moreover, the ability of glass to withstand extreme temperatures during sterilization processes ensures the integrity of drugs, aligning with stringent regulatory requirements. For instance, in July 2023, Corning Inc. launched Viridian Vials, a breakthrough in pharmaceutical glass packaging that aligns with the industry's focus on sustainability and efficiency. Viridian Vials' low-friction coating minimizes cracks and breaks, enhancing filling-line efficiency by up to 50%, demonstrating the impact of advancements in drug delivery technologies on the pharmaceutical glass packaging market.
- High Sustainable Packaging Preferences
Growing environmental concerns and awareness among the consumers and pharmaceutical companies increasingly favor glass packaging due to its recyclability and minimal environmental impact. Glass is a highly sustainable material, being infinitely recyclable without loss of quality, which aligns with global efforts to reduce waste and carbon footprints. Pharmaceutical glass packaging also supports sustainability goals by reducing the reliance on single-use plastics and promoting eco-friendly practices. This shift towards greener packaging solutions drives the demand for glass containers in the pharmaceutical industry, reinforcing their role as a preferred packaging material.
Restraints/Challenges
- High Production Costs for Manufacturers
Manufacturing pharmaceutical-grade glass packaging requires high-quality raw materials and advanced production technologies, leading to substantial expenses. The process involves stringent quality control measures to meet regulatory standards, further escalating costs. These high production costs can be prohibitive for smaller pharmaceutical companies, limiting their ability to adopt glass packaging. Additionally, the financial burden of maintaining and upgrading manufacturing facilities to ensure compliance with evolving regulations adds to the overall expense, impacting the market's growth potential.
- Competition from Alternative Materials
Alternative materials often offer cost advantages, greater durability, and lighter weight, making them attractive for pharmaceutical packaging. Advances in polymer technology have enhanced their barrier properties, safety features, and sustainability, further challenging the dominance of glass. The versatility and streamlined manufacturing process of plastic containers result in accelerated production timelines and reduced expenses which makes them a strong competitor against traditional glass packaging solutions. This competition pressures the glass packaging market to innovate and justify its higher costs and fragility.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Recent Development
- In May 2023, Nipro PharmaPackaging International NV, a subsidiary of Nipro Corporation, acquired Piramida, a prominent Croatian glass pharmaceutical packaging producer. The acquisition, following Piramida's impressive growth under Blue Sea Capital's ownership, underscores Nipro's dedication to expanding its footprint in European and global pharmaceutical packaging markets
- In September 2022, Gerresheimer AG and StevanatoGroup SpA collaborated to develop a high-end ready-to-use (RTU) solution platform, focusing initially on vials using StevanatoGroup's EZ-fill technology. This partnership promises customers increased productivity, higher quality standards, faster time to market, lower total cost of ownership (TCO), and reduced supply chain risks
- In July 2022, Nipro Corporation Japan invested HRK 100 million in a new glass packaging plant in Croatia. The facility, located in Zagreb's suburb Sesvete, specializes in producing glass ampoules and vials for pharmaceuticals, aiming to meet the demand for life-saving drugs
Pharmaceutical Glass Packaging Market Scope
The market is segmented on the basis of the material, product, drug type, application, and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Material
- Type I
- Type II
- Type III
Product
- Bottles
- Ampoules
- Cartridges and Syringes
- Vials
- Others
Drug Type
- Generic
- Branded
- Biologic
Application
- Oral
- Injectable
- Nasal
- Others
End-Use
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Contract Development
- Manufacturing Companies
- Compound Pharmacy
- Others
Middle East and Africa Pharmaceutical Glass Packaging Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by material, product, drug type, application, and end-use as referenced above.
The countries covered in the market report are U.A.E., Saudi Arabia, Egypt, South Africa, Israel, Africa, and rest of Middle East and Africa.
U.A.E. is expected to dominate the market, propelled by rapid urbanization and heightened consumer awareness regarding diverse pharmaceutical glass packaging solutions. This trend reflects a burgeoning demand for advanced packaging options that ensure product safety, quality, and longevity in the rapidly expanding urban landscape of the U.A.E. With a proactive approach to meet evolving consumer needs and industry standards, the U.A.E. solidifies its position as a key player in shaping the future of pharmaceutical packaging solutions regionally and globally.
Saudi Arabia is expected to experience significant growth in the market due to rising demand within the pharmaceutical sector. Factors such as population growth, expanding healthcare infrastructure, and increasing pharmaceutical production contribute to this surge. Additionally, stringent regulations promoting the use of high-quality packaging for medicines further drive the market. As the pharmaceutical industry expands and innovates, Saudi Arabia emerges as a key market for pharmaceutical glass packaging manufacturers, presenting lucrative opportunities for growth and investment.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Pharmaceutical Glass Packaging Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to the market.
Some of the major players operating in the market are:
- RAK Ghani Glass LLC (U.A.E.)
- APG (Asia Pulp & Paper Group) (Indonesia)
- Middle East Glass – MEG (Egypt)
- Bormioli Pharma S.p.a (Italy)
- FRIGOGLASS AG (Switzerland)
- Medicinal Glass CO., Ltd. (China)
SKU-